The diagnostic imaging center industry is a critical component of the healthcare sector, providing essential services for the detection, diagnosis, and monitoring of various medical conditions. These facilities utilize advanced imaging technologies such as X-rays, Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Ultrasound, and Positron Emission Tomography (PET) to produce detailed images of the body’s internal structures. M&A activity in this sector has remained steady as health...

The addiction treatment industry is a vital and rapidly evolving segment of the behavioral healthcare market, focused on the diagnosis and treatment of substance use disorders (SUDs), including alcohol, opioids, stimulants, and other drugs. Services range from detoxification and inpatient rehabilitation to outpatient therapy and medication-assisted treatment (MAT). M&A activity in the sector is driven by private equity interest in scalable treatment platforms, especially those offering a full...

The dermatology industry has been a hotbed of M&A activity for a decade now, driven by strong cash flow, predictable patient demand, and a balanced mix of medical and elective services. Private equity firms and strategic buyers are actively consolidating the space, targeting practices with multiple providers, ancillary revenue streams, and scalable operations. As competition increases, well-managed dermatology groups with diversified services and payer stability are commanding premium...